-transparent.png){kind=logo}
In serum samples from 37 patients with ankylosing spondylitis (AS), immune complexes were quantitated by the 125I-Clq binding test; in paired plasma samples the C3 breakdown product C3d was measured by an immunochemical method. Compared to results in 30 blood donors, the Clq binding activity was significantly (greater than 2 SD), although discretely, increased in 5 of 8 patients with seropositive AS, but not in other AS patients. All C3d levels were within the normal range. In a parallel investigation, increased Clq binding activity and C3d levels were found in 87% and 90%, respectively, of patients with seropositive rheumatoid arthritis.
Related Publications
R Gabay, and
R H Zubler, and
U E Nydegger, and
P H Lambert
January 1992,
Annals of the rheumatic diseases,
R Gabay, and
R H Zubler, and
U E Nydegger, and
P H Lambert
November 1983,
British journal of rheumatology,
R Gabay, and
R H Zubler, and
U E Nydegger, and
P H Lambert
November 1983,
British journal of rheumatology,
R Gabay, and
R H Zubler, and
U E Nydegger, and
P H Lambert
April 1981,
Medicina clinica,
R Gabay, and
R H Zubler, and
U E Nydegger, and
P H Lambert
October 1980,
Annals of the rheumatic diseases,
R Gabay, and
R H Zubler, and
U E Nydegger, and
P H Lambert
January 1982,
Clinical and investigative medicine. Medecine clinique et experimentale,
R Gabay, and
R H Zubler, and
U E Nydegger, and
P H Lambert
February 1981,
Clinical immunology and immunopathology,
R Gabay, and
R H Zubler, and
U E Nydegger, and
P H Lambert
April 1978,
Annals of the rheumatic diseases,
R Gabay, and
R H Zubler, and
U E Nydegger, and
P H Lambert
January 1981,
Rheumatology international,
R Gabay, and
R H Zubler, and
U E Nydegger, and
P H Lambert
November 2007,
European journal of medical research,
